Related Experiment Video
Updated: Oct 29, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine
F Ronchi1, P Cecchi, F Falcioni
1Divisione Pediatrica-Ospedale Civile di Cattolica (RN), Cattolica (RN), Italy.
Abstract:
Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against polio, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.
Related Concept Videos
Hypersensitivity Reactions: Cytolytic Reactions
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Hepatitis
Drug toxicity: Idiosyncratic Reactions
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.